Researchers

Omico provides access to an intellectually rich network of patient-centred research possibilities, from fundamental research to clinical trials and real-world studies that will change clinical care.

The Omico network sees more than 20,000 new cancer patients each year. Participating research institutions, with a collective research workforce of more than 1,500 basic and clinical researchers, undertake world-class research to accelerate the translation of discovery science into clinical practice.

Why partner with us?

Discover therapeutic avenues for patient with advanced cancers
Develop basic and translational research into applications of genomics in clinical management
Enhance Australian competitiveness as a destination for early phase clinical trials for the global pharmaceutical sector
Develop an innovative and a sustainable eco-sytem involving consumers, academic cancer centres, medical researchers and industry partners, to outsmart cancer, together.

Building on strong foundations

Working with us means access to:

A national network of thought-leaders, clinicians and researchers, effectively working together to close the gap between science and medicine
State-of-the-art resources for genomics and correlative science
Existing and productive industry, community and academic partnerships
Statistically powered, efficient and cost-effective mechanisms for conducting biomarker-driven clinical research in the right cancer populations.

Our programs

Learn More

Interested in knowing more?

Get in touch